ALC:NYSE
Alcon
73,64 $
arrow_downward
-0,65%(-0,48) 1D
73,64 $
0,00% (0,00)
bedtimeAfter hours
Closed: 16 նոյ, 16:00:05 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
74,35 $
High
74,76 $
Low
73,50 $
Mkt. cap
31,19 մլրդ
Avg. vol.
2,14 մլն
Volume
1,77 մլն
52-wk high
87,64 $
52-wk low
61,84 $
Beta
0,87
Shares outstanding
483,40 մլն
No. of employees
25 հզր
Open
74,35 $
High
74,76 $
Low
73,50 $
Mkt. cap
31,19 մլրդ
Avg. vol.
2,14 մլն
Volume
1,77 մլն
52-wk high
87,64 $
52-wk low
61,84 $
Beta
0,87
Shares outstanding
483,40 մլն
No. of employees
25 հզր
News stories
From web sources and news partners
marketscreener.com
·
1 ժամ առաջ
Nasdaq, S&P 500 Fall For Third Day as Nvidia Sell-Off Continues
Investing.com
·
1 ժամ առաջ
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
ChartMill
·
2 ժամ առաջ
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
BigGo Finance
·
8 ժամ առաջ
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon
CEODavid J. Endicott
Employees25 հզր
Founded1945
HeadquartersԺնև, Ժնև, Շվեյցարիա
SectorHealth Care
Industry-
Websitealcon.com